진행성 유방암에 대한 한양방 병용 치료 치험 1례
A Case Study of an Advanced Breast Cancer Patient Treated with a Combination of Traditional Korean Medicine and Chemotherapy
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Although patients with breast cancer receive standard treatments, they often experience recurrence or metastasis of tumors. Therefore, patients seeking treatment with traditional Korean medicine (TKM) in addition to conventional treatment have increased. We present a case of 46-year-old female with recurring breast cancer. She underwent surgeries and various hormone therapies since being diagnosed in 2007. Upon follow-up examination, she had metastatic lesions on the lung and multiple bones in 2015 and 2016. She received TKM treatments from May 2017 with Aromasin and Afinitor. However, hepatic metastasis was found after two months, so she started Capecitabine with TKM. After about two months, the liver nodules disappeared and a seeding nodule in the right paracolic gutter was decreased. After two months, the tumor response was stable disease. Back pain due to bone metastasis was improved. We suggest that combination treatment of TKM and chemotherapy is a promising method for treating breast cancer.
Abstract
Although patients with breast cancer receive standard treatments, they often experience recurrence or metastasis of tumors. Therefore, patients seeking treatment with traditional Korean medicine (TKM) in addition to conventional treatment have increased. We present a case of 46-year-old female with recurring breast cancer. She underwent surgeries and various hormone therapies since being diagnosed in 2007. Upon follow-up examination, she had metastatic lesions on the lung and multiple bones in 2015 and 2016. She received TKM treatments from May 2017 with Aromasin and Afinitor. However, hepatic metastasis was found after two months, so she started Capecitabine with TKM. After about two months, the liver nodules disappeared and a seeding nodule in the right paracolic gutter was decreased. After two months, the tumor response was stable disease. Back pain due to bone metastasis was improved. We suggest that combination treatment of TKM and chemotherapy is a promising method for treating breast cancer.
참고문헌 (23)
- Park B, "Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey", Asian Pac J Cancer Prev, 13(4), pp.1187~1191 (2012)[DOI]
- 강선희, "재발성 유방암 환자의 생존율 및 예후인자", Annals of Surgical Treatment and Research, 73(3), pp.210~215 (2007), 대한외과학회
- 윤호성, "유방암 환자의 원격재발 후 생존율과 예후인자 분석", Annals of Surgical Treatment and Research, 64(2), pp.101~108 (2003), 대한외과학회
- Park JG, "Oncology", pp.596~ (2012), Ichokak
- 우희두, "한국 유방암 환자에서 TAC 보조항암화학요법의 독성 및 내성에 대한 연구", Journal of Breast Cancer, 14, pp.44~49 (2011), 한국유방암학회
- 서지영, "항암화학요법을 받는 암 환자의 디스트레스와 삶의 질", Asian Oncology Nursing, 15(1), pp.18~27 (2015), 대한종양간호학회
- 이강욱, "유방암 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구", 대한한방부인과학회지, 29(2), pp.47~65 (2016), 대한한방부인과학회[DOI]
- 김지혜, "재발성 비소세포성 폐암환자의 Afatinib과 삼칠충초정 병용투여 경과관찰 1례", 대한한방내과학회지, 38(1), pp.72~80 (2017), 대한한방내과학회
- Li X, "Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese", PLoS One, 8(4), pp.e60338~ (2013)[DOI]
- Greenlee H, "Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer", J Natl Cancer Inst Monogr, 2014(50), pp.346~358 (2014)[DOI]
- Eisenhauer EA, "New response evaluation criteria in solid tumours: Revised RECIST guideline(version 1.1)", Eur J Cancer, 45(2), pp.228~247 (2009)[DOI]
- "Common Terminology Criteria for Adverse Events(CTCAE) v.4.0"[URL]
- Cho DI, "The literature review for prescription of static blood", Daejeon University Korean Medicine Research Institute, 5(2), pp.265~279 (1997)
- Park JA, "A Study on the Effect of Samchilgeun(San qi gen) on Thrombosis and elevated Blood Viscosity", JPPKM, 7(1), pp.15~26 (1992)
- Wang W, "Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2", PLoS One, 7(7), pp.e41586~ (2012)[DOI]
- Wang P, "Panax notoginseng saponins (PNS) inhibits breast cancer metastasis", J Ethnopharmacol, 154(3), pp.663~671 (2014)[DOI]
- -Gingerol, a major phenolic constituent of ginger root, induces cell cycle arrest and apoptosis in triple-negative breast cancer cells, "Exp Mol Pathol", 2017, 370~376, 10.1016[DOI]
- Jiang K, "Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1", MAPK signaling, 2017, pp.42, 195~202
- Bang SH, "Two cases of Non-Small Lung Cancer Treated with Intravenous Cultivated Wild ginseng Pharmacopuncture", Journal of Phramacopuncture, 11(2), pp.13~19 (2008)
- Jia WW, "Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy", Can J Physiol Pharmacol, 82(7), pp.431~437 (2004)[DOI]
- Blum JL, "The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer", Oncologist, 6(1), pp.56~64 (2001)[DOI]
- Blum JL, "Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer", J Clin Oncol, 17(2), pp.485~493 (1999)[DOI]
- 한솔아, "유방암 환자의 항암 치료 부작용 및 한의학적 보완치료 경험에 관한 포커스 그룹 연구", 대한한방부인과학회지, 30(1), pp.85~94 (2017), 대한한방부인과학회[DOI]